TJP2 and hepatocellular carcinoma: TJP2 mutations may increase the risk of HCC through junction-related effects (as tight junctions can regulate cell growth and proliferation) or through junction-unrelated effects (as the encoded ZO-2 protein may serve as a regulator of gene expression).